Tolerx

Biotechnology Research • Cambridge, Massachusetts, United States • 1-10 Employees

Company overview

Headquarters	300 Technology Square, 3rd Floor, Cambridge, MA 02139, US
Phone number	+17205936478
Website	tolerx.com
Keywords	Biotechnology, Immunotherapy, Cancer Treatment, Antibody Treatment, Autoimmune Disease, Diabetes Treatment
Founded	2000
Employees	1-10
Socials

Key Contact at Tolerx

Mary Matthew

Director, Regulatory Affairs

About Tolerx

Tolerx, Inc., a world leader in immunology, has a portfolio of innovative, first-in-class drug candidates to treat type 1 diabetes, other autoimmune diseases, and cancer by normalizing immune responses. The company’s pipeline includes its lead candidate, otelixizumab, a targeted T cell immunotherapy in Phase 3 development for type 1 diabetes, for which Tolerx is partnered with GlaxoSmithKline. A second clinical product candidate, TRX518, is a targeted T cell immunotherapy in Phase 1 development for cancer. TRX1, a third immunotherapy candidate, is an anti-CD4 antibody that has been clinically evaluated for the treatment of aberrant or untoward immune responses. The company also has two preclinical candidates, TRX585 and TRX385, which enhance immune responses and are being evaluated for potential benefit in the treatment of cancer and chronic viral infections. Tolerx is a privately held company headquartered in Cambridge, MA USA.

Tolerx revenue & valuation

Annual revenue	$10,300,000
Revenue per employee	$1,134,000
Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues	$32,700,000
Total funding	$1,500,000

Employees by Management Level

Total employees: 1-10

Seniority

Employees

Entry

C-Suite

Director

Employees by Department

Tolerx has 6 employees across 4 departments.

Departments

Number of employees

Funding Data

Explore Tolerx's funding history, including investment rounds, total capital raised, and key backers.

Funding Date	Round	Amount	Link to Article
2011-01-01	1	$1,500,000

Funding Insights

$1,500,000

Total funding amount

$1,500,000

Most recent funding amount

Number of funding rounds

Frequently asked questions

Tolerx is located in Cambridge, Massachusetts, US.

You can reach Tolerx at +17205936478.

Tolerx was founded in 2000, making it 26 years old. The company has established itself as a significant player in its industry over this time.

Tolerx has approximately 1-10 employees. The company continues to grow its workforce to support its business operations and expansion.

Tolerx has raised a total of $1,500,000 across 1 funding rounds. This investment has helped the company grow and expand its operations.

Key Contact at Tolerx

Mary Matthew

Director, Regulatory Affairs

4.8

40,000 users